Abstract
The New Drugs column informs readers about new chemical and biologic entities approved for marketing by the U.S. Food and Drug Administration. The column is written by Contributing Editor Daniel A. Hussar, PhD, Remington Professor of Pharmacy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA. Daniel A. Hussar, PhD, Remington Professor of Pharmacy, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA Rachel C. Boardman, PharmD, PGY-1 Resident, Wake Forest Baptist Health, Winston-Salem, NC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.